FDA inspection
Karyopharm Therapeutics Inc.: FDA inspection ending Mar 15, 2023
FDA inspection 1202243 · No Action Indicated (NAI) · Newton, MA
Key facts
| Inspection ID | 1202243 |
|---|---|
| Firm | Karyopharm Therapeutics Inc. |
| FEI number | 3012640137 |
| Address | 85 Wells Ave Fl 2 |
| City | Newton |
| State | MA |
| ZIP | 02459 |
| Country | United States |
| Fiscal year | 2023 |
| Inspection end date | Mar 15, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data